Crossmark

In vitro growth inhibitory activity of Medicines for Malaria Venture pathogen box compounds against Leishmania aethiopica

Published Online: 2021-11-16

Published Print: 2021-12

Authors

Tadele, Markos

Abay, Solomon M.

Asaga, Peter

Makonnen, Eyasu

Hailu, Asrat
License Information

Text and Data Mining valid from 2021-11-16

Version of Record valid from 2021-11-16
More Information

Article History

Received: 28 January 2021

Accepted: 28 October 2021

First Online: 16 November 2021

Declarations

:

: Ethical approval was obtained from the Departmental Research Ethics Committee, Department of Pharmacology and Clinical Pharmacy, School of Pharmacy, College of Health Sciences, Addis Ababa University (ERB/SOP/37/10/2018 dated Jan 01, 2018). Informed consent was obtained from the patient shortly after diagnosis which permits the use of the isolate for research purposes. Confidentiality and privacy kept by omitting the name of the patient. All procedures and techniques used in this study were per the national institute of health guidelines for the care and use of laboratory animals (Institute for Laboratory Animal Research, 2011) and following the ARRIVE Guidelines Checklist.

: Not applicable.

: There are no competing interests in this work.

Document is current